Cholangitis - 59 Studies Found
| Completed |
: A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. : Primary Sclerosing Cholangitis : 2025-08-03 : Oral Tablet |
| Completed |
: Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis. : Primary Sclerosing Cholangitis : 2025-08-03 : Hymecromone 400 mg 3 times daily by mouth. |
| Completed |
: Antibiotics to Decrease Post ERCP Cholangitis : Cholangitis : 2025-08-03 : Intravenous Ceftriaxone will be given during the procedure. |
| Completed |
: Efficacy and Safety of Single-session Endoscopic Stone Extraction : Choledocholithiasis With Acute Cholangitis : 2025-08-03 : early endoscopic drainage followed by endoscopic stone extraction |
| COMPLETED |
: Endoscopy and Primary Sclerosing Cholangitis : Primary Sclerosing Cholangitis (PSC) : 2025-08-03 : ERCP is an endoscopic therapeutic procedure to drain the bile ducts in case of stones or biliary strictures that can be treated by balloon dilatation |
| COMPLETED |
: Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions : Primary Biliary Cholangitis : 2025-08-03 : Online program (mindful movement, meditation, breathwork, psychology-based coping skills program) |
| COMPLETED |
: An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI) : Primary Biliary Cholangitis : 2025-08-03 : Seladelpar 10 mg single oral dose |
| COMPLETED |
: A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis. : Primary Biliary Cholangitis : 2025-08-03 : K-808 single or multi dose extended-release tablets |
| COMPLETED |
: A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury : Primary Biliary Cholangitis : 2025-08-03 : Single oral dose of CS0159 4mg |